The PSMA-binding affinities (IC50) (Fig. 3A) were determined in a competitive binding assay on LNCaP human prostate carcinoma cells, using (125I-I-BA)KuE as radioligand. This evidence concerns the gene FOLH1 and prostate carcinoma.